Company Overview

Encompass Health Corporation is the largest owner and operator of inpatient rehabilitation hospitals in the United States, distinguished by the number of patients treated, revenue generated, and the sheer volume of its facilities. The company manages a network of 169 hospitals dedicated to providing advanced therapy and nursing services through a holistic care delivery model.

Previously known as HealthSouth Corporation, the company officially adopted its current name, Encompass Health Corporation, in January 2018. Incorporated in 1984, Encompass Health Corporation is headquartered in Birmingham, Alabama.

Business Operations

Primary Services

Encompass Health's core business involves owning and operating inpatient rehabilitation hospitals. These facilities offer comprehensive medical, nursing, therapy, and ancillary services, providing specialized inpatient rehabilitative treatment for a wide range of acute medical conditions. These include recovery from strokes, hip fractures, and various other debilitating neurological conditions.

The company's operations are segmented into two primary divisions:

- Inpatient Rehabilitation: This segment comprises inpatient rehabilitation hospitals that deliver intensive rehabilitative treatment and care to patients recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic issues, and amputations.

- Home Health and Hospice: This segment offers Medicare-certified home nursing, specialized home care, and in-home services, extending care beyond the hospital setting.

Geographic Coverage

Encompass Health's hospital network is predominantly situated in the eastern half of the United States and Texas. The company serves a diverse payer base, including federal government programs (like Medicare), managed care plans, private insurers, state governments, and other private patients.

Financial Performance and Market Position

The company's financial performance demonstrates consistent growth and a strong market standing. Encompass Health is the leading operator in the inpatient rehabilitation sector, evidenced by its revenue growth and profitability metrics.

Recent Financial Performance

Q2 2025 Results (ended June 30, 2025)

Revenue saw a significant increase of 12.0%, driven by higher patient discharge volumes and favorable pricing. Key performance indicators include:

- Total Discharges: Grew by 7.2%, with same-store growth contributing 4.7%.

- Net Patient Revenue per Discharge: Increased by 4.2%.

- Cash Flows from Operations: Rose by 24.3% to $270.2 million, largely attributable to an uplift in net income.

- Adjusted EBITDA: Experienced a 17.2% increase, benefiting from revenue growth and expense leverage.

Revenue Trends

Encompass Health reported revenue of $1.458 billion for the quarter ending June 30, 2025, marking a 12.03% year-over-year increase. For the twelve months ending June 30, 2025, total revenue reached $5.669 billion, an 11.8% increase year-over-year. The full annual revenue for 2024 was $5.373 billion, representing an 11.91% growth from 2023.

Key Financial Metrics

- Net Margin: 8.41% (Surpasses industry standards, indicating strong cost management and profitability).

- Return on Equity (ROE): 5.87% (Demonstrates effective use of equity capital).

- Return on Assets (ROA): 1.82% (Signifies efficient asset management and financial health).

- Debt-to-Equity Ratio: 1.31 (Below the industry average, suggesting a conservative financial approach and lower reliance on debt financing).

Expansion Initiatives

Encompass Health is actively pursuing the expansion of its network capacity to meet the growing demand for inpatient rehabilitation care. During Q2 2025, the company enhanced its service provision by opening a new 60-bed hospital in Fort Myers, Florida, and adding 26 beds to an existing facility.

Market Position and Investor Outlook

Stock Performance and Market Position

The company's market capitalization indicates a substantial presence within its industry, often suggesting a higher degree of investor confidence and market recognition compared to smaller peers.

Analyst Outlook

Encompass Health benefits from a positive analyst consensus, holding a "Strong Buy" rating. This rating is based on 9 'Buy' recommendations, with no 'Hold' or 'Sell' ratings. The average price target stands at $137.67, with forecasts ranging from a low of $130.00 to a high of $145.00.

Dividend Policy

Management maintains a consistent commitment to shareholder returns through dividend payments. The company distributed a quarterly cash dividend of $0.17 per share, reflecting its strategy of sharing value with its investors.

Industry Position

Encompass Health leads its peers in terms of revenue growth and boasts the highest gross profit margin in the inpatient rehabilitation sector. Its established leadership, coupled with an aging population and the increasing demand for post-acute care services, strongly positions the company for sustained growth.

Encompass Health operates within a specialized niche of the healthcare sector, focusing on rehabilitation services that serve as a critical bridge between acute hospital care and home-based recovery. This focus caters to patients requiring intensive rehabilitative treatment to regain independence and successfully reintegrate into their communities.